Medicine catalog

Search official names, active ingredients, and BDPM codes. Cards show a readable name and form; the exact French source details are available below.

Total in catalog: 20,854 · 19 shown

Commercialized according to BDPM

SARCLISA 20 mg/ml, concentrate for solution for infusion

Active ingredients: Isatuximab

Original BDPM details in French

Official name: SARCLISA 20 mg/mL, solution à diluer pour perfusion
Active ingredients: ISATUXIMAB
Package description: 1 flacon(s) en verre de 5 ml

CIS 66510210CIP7 5507404CIP13 3400955074045

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

SARCLISA 20 mg/ml, concentrate for solution for infusion

Active ingredients: Isatuximab

Original BDPM details in French

Official name: SARCLISA 20 mg/mL, solution à diluer pour perfusion
Active ingredients: ISATUXIMAB
Package description: 1 flacon(s) en verre de 25 ml

CIS 66510210CIP7 5507406CIP13 3400955074069

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

ADCETRIS 50 mg, powder for concentrate for infusion

Active ingredients: BRENTUXIMAB VÉDOTINE

Original BDPM details in French

Official name: ADCETRIS 50 mg, poudre pour solution à diluer pour perfusion
Active ingredients: BRENTUXIMAB VÉDOTINE
Package description: 1 flacon(s) en verre

CIS 68438457CIP7 5839718CIP13 3400958397189

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

ELAHERE 5 mg/ml, concentrate for solution for infusion

Active ingredients: MIRVÉTUXIMAB SORAVTANSINE

Original BDPM details in French

Official name: ELAHERE 5 mg/mL, solution à diluer pour perfusion
Active ingredients: MIRVÉTUXIMAB SORAVTANSINE
Package description: 1 flacon en verre de 20 mL

CIS 65505616CIP7 5510458CIP13 3400955104582

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

ERBITUX 5 mg/ml, solution for infusion

Active ingredients: CÉTUXIMAB

Original BDPM details in French

Official name: ERBITUX 5 mg/ml, solution pour perfusion
Active ingredients: CÉTUXIMAB
Package description: 1 flacon(s) en verre de 20 ml

CIS 66843357CIP7 5707508CIP13 3400957075088

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

ERBITUX 5 mg/ml, solution for infusion

Active ingredients: CÉTUXIMAB

Original BDPM details in French

Official name: ERBITUX 5 mg/ml, solution pour perfusion
Active ingredients: CÉTUXIMAB
Package description: 1 flacon(s) en verre de 100 ml

CIS 66843357CIP7 5707520CIP13 3400957075200

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

MABTHERA 100 mg, concentrate for solution for infusion

Active ingredients: Rituximab

Original BDPM details in French

Official name: MABTHERA 100 mg, solution à diluer pour perfusion
Active ingredients: RITUXIMAB
Package description: 2 flacon(s) en verre

CIS 65348481CIP7 5606003CIP13 3400956060030

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

MABTHERA 1400 mg, solution for injection subcutaneous

Active ingredients: Rituximab

Original BDPM details in French

Official name: MABTHERA 1400 mg, solution pour injection sous-cutanée
Active ingredients: RITUXIMAB
Package description: 1 flacon(s) en verre

CIS 65314657CIP7 5865992CIP13 3400958659928

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

MABTHERA 500 mg, concentrate for solution for infusion

Active ingredients: Rituximab

Original BDPM details in French

Official name: MABTHERA 500 mg, solution à diluer pour perfusion
Active ingredients: RITUXIMAB
Package description: 1 flacon(s) en verre

CIS 62002638CIP7 5606026CIP13 3400956060269

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

QARZIBA 4.5 mg/ml, concentrate for solution for infusion

Active ingredients: Dinutuximab

Original BDPM details in French

Official name: QARZIBA 4,5 mg/ml, solution à diluer pour perfusion
Active ingredients: DINUTUXIMAB BÊTA
Package description: 1 flacon(s) en verre de 20 mg

CIS 68429472CIP7 5503327CIP13 3400955033271

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

RIXATHON 100 mg, concentrate for solution for infusion

Active ingredients: Rituximab

Original BDPM details in French

Official name: RIXATHON 100 mg, solution à diluer pour perfusion
Active ingredients: RITUXIMAB
Package description: 2 flacon(s) en verre de 10 ml

CIS 64018979CIP7 5503445CIP13 3400955034452

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

RIXATHON 500 mg, concentrate for solution for infusion

Active ingredients: Rituximab

Original BDPM details in French

Official name: RIXATHON 500 mg, solution à diluer pour perfusion
Active ingredients: RITUXIMAB
Package description: 1 flacon(s) en verre de 50 ml

CIS 68929381CIP7 5503446CIP13 3400955034469

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

RUXIENCE 100 mg, concentrate for solution for infusion

Active ingredients: Rituximab

Original BDPM details in French

Official name: RUXIENCE 100 mg, solution à diluer pour perfusion
Active ingredients: RITUXIMAB
Package description: 1 flacon en verre de 10 mL

CIS 67613747CIP7 3020594CIP13 3400930205945

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

RUXIENCE 500 mg, concentrate for solution for infusion

Active ingredients: Rituximab

Original BDPM details in French

Official name: RUXIENCE 500 mg, solution à diluer pour perfusion
Active ingredients: RITUXIMAB
Package description: 1 flacon en verre de 50 mL

CIS 66217549CIP7 3020600CIP13 3400930206003

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

SYLVANT 400 mg, powder for concentrate for infusion

Active ingredients: Siltuximab

Original BDPM details in French

Official name: SYLVANT 400 mg, poudre pour solution à diluer pour perfusion
Active ingredients: SILTUXIMAB
Package description: 1 flacon(s) en verre

CIS 63846800CIP7 5869174CIP13 3400958691744

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

TRUXIMA 100 mg, concentrate for solution for infusion

Active ingredients: Rituximab

Original BDPM details in French

Official name: TRUXIMA 100 mg, solution à diluer pour perfusion
Active ingredients: RITUXIMAB
Package description: 2 flacon(s) en verre de 10 ml

CIS 64237955CIP7 3010537CIP13 3400930105375

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

TRUXIMA 500 mg, concentrate for solution for infusion

Active ingredients: Rituximab

Original BDPM details in French

Official name: TRUXIMA 500 mg, solution à diluer pour perfusion
Active ingredients: RITUXIMAB
Package description: 1 flacon(s) en verre de 50 ml

CIS 64102473CIP7 3008303CIP13 3400930083031

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

VYLOY 100 mg, powder for concentrate for infusion

Active ingredients: ZOLBÉTUXIMAB

Original BDPM details in French

Official name: VYLOY 100 mg, poudre pour solution à diluer pour perfusion
Active ingredients: ZOLBÉTUXIMAB
Package description: 1 flacon en verre de 20 mL

CIS 62607473CIP7 5510399CIP13 3400955103998

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

VYLOY 300 mg, powder for concentrate for infusion

Active ingredients: ZOLBÉTUXIMAB

Original BDPM details in French

Official name: VYLOY 300 mg, poudre pour solution à diluer pour perfusion
Active ingredients: ZOLBÉTUXIMAB
Package description: 1 flacon(s) en verre de 20 ml

CIS 68841351CIP7 5510720CIP13 3400955107200

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

The displayed price is an estimate. It is not an offer to sell or confirmation of stock. Current catalog version published 4 Nov 2026.